Dataset Information
Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale supporting CD44-induced AML differentiation therapy.
Ontology highlight
ABSTRACT:
SUBMITTER: Gadhoum SZ
PROVIDER: S-EPMC5155032 | biostudies-literature | 2016 Dec
REPOSITORIES: biostudies-literature